India's drug regulatory body is intensifying its scrutiny of the distribution channels for GLP-1 weight loss drugs. State drug authorities are directed to ensure stringent compliance with approved protocols and accurate product labeling. Any instances of unauthorized sale or marketing will invite strict legal action. The agency is also keeping a close watch on promotional activities across different platforms.